IndraLab
Statements
reach
"Because autocrine IL-1R signaling is a critical component that drives the canonical NF-kb cascade in PDAC, the combination of the IL-1R antagonist Anakinra with nab-paclitaxel, gemcitabine, and cisplatin has been opened in a pilot clinical trial for patients with resectable or potentially resectable PDAC (NCT02550327)."
sparser
"A well-characterized example of a complete self-regulated inflammatory pathway is the interleukin-1 (IL-1) system comprising the agonist cytokines IL-1α and IL-1β, and their receptor IL-1R1 (IL-1 receptor type I), which is inhibited by the IL-1 receptor antagonist IL-1Ra. xref A related system involves the three IL-36 cytokines IL-36α, IL-36β and IL-36γ, which are neutralized when the IL-36Ra binds the IL-36 receptor IL-1RL2 (also known as IL-36R)."
reach
"The advantage of this approach is that some of these drugs are already available in the clinic for the treatment of auto-inflammatory or autoimmune diseases, such as the IL-1R antagonist anakinra, the IL-1α antagonist canakinumab, the IL-6 receptor antagonist tocilizumab, and the TNF-α antibody infliximab or the TNFα receptor fusion protein etanercept."
reach
"The proinflammatory cytokine IL1β also might contribute to TAN accumulation, polarization, and survival in the TME.109 Here again, combining the anti-IL1β antibody canakinumab or the IL1R antagonist anakinra with ICIs in clinical trials might affect both IL1β-mediated cancer cell proliferation and TANs (table 1)."
reach
"Treatment of animals having had tibia fracture and cast immobilization with IL-1R antagonist anakinra reduces not only the CRPS-like nociceptive sensitization, but also levels of the pro-nociceptive mediators IL-6, tumor necrosis factor α and nerve growth factor in hindpaw skin (12)."
reach
"Since blockade of IL-1R by anakinra reduced leukocyte levels in both HPV-positive and HPV-negative OPSCC in vitro, it could be argued that this antagonist may be effective for both types of tumour, however, the increased numbers of leukocytes recruited to HPV-negative OPSCC suggests that the treatment would be most effective for this cancer type."
reach
"More recently, based on our initial report of efficacy in a child with FIRES (Kenney-Jung et al., 2016; Clarkson et al., 2019), the IL-1R antagonist anakinra has been increasingly used in the treatment of these patients, with mixed results (Farias-Moeller et al., 2018; Löscher and Klein, 2021a; Yamanaka et al., 2021)."